Par-1, -4, and the mTOR pathway following Germinal Matrix Hemorrhage

Tim Lekic, Paul R. Krafft, Damon Klebe, Jerry Flores, William B. Rolland, Jiping Tang, John H. Zhang

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Abstract

Germinal matrix hemorrhage (GMH) is the most common cause of neurological complications of prematurity and has lasting implications. PAR-1 and PAR-4 receptors are involved with upstream signaling pathways following brain hemorrhage in adult models of stroke, of which the mammalian target of rapamycin (mTOR) is a potential downstream mediator. Therefore, we hypothesized a role for PAR-1, -4/ mTOR signaling following GMH brain injury. Postnatal day 7 Sprague-Dawley rats were subjected to GMH through stereotactic infusion of collagenase into the right ganglionic eminence. Rodents were euthanized at 72 h (short term), or 4 weeks (long term). Short-term mTOR expression was evaluated by Western blot in the context of PAR-1 (SCH-79797) and PAR-4 (P4pal10) inhibition. Pups in the long-term group were administered the selective mTOR inhibitor (rapamycin) with neurobehavioral and brain pathological examinations performed at 4 weeks. Pharmacological PAR-1, -4 antagonism normalized the increased mTOR expression following GMH. Early inhibition of mTOR by rapamycin improved long-term outcomes in rats. Mammalian-TOR signaling plays an important role in brain injury following neonatal GMH, possibly involving upstream PAR-1, -4 mechanisms.

Original languageEnglish
Title of host publicationBrain Edema XVI
PublisherSpringer Cham
Pages213-216
Number of pages4
Volume121
ISBN (Electronic)978-3-319-18497-5
ISBN (Print)978-3-319-18496-8, 978-3-319-36532-9
DOIs
StatePublished - Jan 1 2016

Publication series

NameActa Neurochirurgica, Supplementum
Volume121
ISSN (Print)0065-1419
ISSN (Electronic)2197-8395

ASJC Scopus Subject Areas

  • Surgery
  • Clinical Neurology

Keywords

  • Animals, Newborn
  • Pyrroles/pharmacology
  • Rats
  • Quinazolines/pharmacology
  • Thrombin/metabolism
  • Rats, Sprague-Dawley
  • Receptors, Thrombin/antagonists & inhibitors
  • Signal Transduction/drug effects
  • Blotting, Western
  • Receptor, PAR-1/antagonists & inhibitors
  • Sirolimus/pharmacology
  • Brain/drug effects
  • TOR Serine-Threonine Kinases/antagonists & inhibitors
  • Animals
  • Behavior, Animal/drug effects
  • Oligopeptides/pharmacology
  • Immunosuppressive Agents/pharmacology
  • Intracranial Hemorrhages/metabolism

Cite this